#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cervix carcinoma recurrent Neuroendocrine carcinoma metastatic Amyotrophic lateral sclerosis gene carrier Extra-osseous Ewing's sarcoma metastatic Ovarian epithelial cancer Spinal cord injury cervical Bladder cancer Thalassaemia Biotinidase deficiency Osteogenesis imperfecta Malignant oligodendroglioma Oropharyngeal cancer recurrent Angelman's syndrome Squamous cell carcinoma of the hypopharynx Chronic kidney disease More trials…

    Learn about Rare Diseases

    Hereditary angioedema – Diagnostics Atypical haemolytic uraemic syndrome – Diagnostics Antithrombin III deficiency – Treatment Focal segmental glomerulosclerosis – Life with Disease Methylmalonic acidaemia Niemann-Pick disease – Trials in Disease Alagille syndrome Hyperoxaluria – Treatment Mucopolysaccharidosis I – Life with Disease Gaucher’s disease type III – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tafasitamab Savolitinib Glatiramer Acetate Lbl-007 Bemarituzumab Fexofenadine Hydrochloride FLUORIDE Izaflortaucipir (18F) Ceralasertib Gentamicin Macrogol 3350 Bms-986435 Quercus Robur Pollen Extract Perampanel Vortioxetine Rosuvastatin Zinc Cenegermin Betibeglogene Autotemcel Tigecycline Argon More therapies…

    Learn about Your Condition

    Clostridium difficile colitis Dementia Acarodermatitis Altered state of consciousness Critical illness Inflammatory bowel disease Retroperitoneal cancer Autism spectrum disorder Rhabdoid tumour Liposarcoma Hypervolaemia Chondroplasty Choroidal neovascularisation Normal pressure hydrocephalus Hepatic adenoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A Study of Saruparib for Patients with Metastatic Pancreatic Cancer with Homologous Repair Deficiency as First Treatment

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • Saruparib
    France

  • A study testing the safety and effects of BAY 3018250 given as a single infusion in increasing doses in healthy men compared to placebo

    Not recruiting

    1 1
    Investigated Diseases:
    • Embolism
    Investigated Drugs:
    • Bay 3018250
    Germany

  • A Study to Test the Safety and Body’s Response to TETRALITE Influenza Vaccine Compared to Vaxigrip Tetra Vaccine in Healthy Adults Aged 18 to 50 Years

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • A/Victoria/2570/2019 (H1N1)Pdm09-Like Strain (A/Victoria/2570/2019, Ivr-215)
    • Influenza Virus A/Darwin/9/2021 San-010 (H3N2)
    • Influenza Virus B/Michigan/01/2021
    Belgium

  • A Study of XC001 Gene Therapy with Bypass Surgery for Patients with Coronary Artery Disease and Weakened Heart Function at Risk for Incomplete Treatment

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Coronary artery disease
    Investigated Drugs:
    • Gadobutrol
    • Regadenoson
    • Adenosine
    Germany Hungary The Netherlands Poland

  • A Study of GSK4524101 and Niraparib for Adults with Advanced Solid Tumors or Metastatic Breast Cancer with BRCA Gene Changes

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • GSK4524101A
    • Niraparib Tosilate Monohydrate
    Belgium Czechia Denmark Estonia Greece Italy +2

  • A Study Comparing Two Formulations of Apixaban in Healthy Volunteers to Test if They Work the Same Way in the Body

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Apixaban
    Spain
Previous Page
1 … 942 943 944 945 946 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!